Fortress Biotech Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
78
- Stock Symbol
-
FBIO
- Investments
-
5
- Share Price
-
$1.98
- (As of Thursday Closing)
Fortress Biotech General Information
Description
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
Contact Information
Website
www.fortressbiotech.comCorporate Office
- 1111 Kane Concourse
- Suite 301
- Bay Harbor Islands, FL 33154
- United States
Corporate Office
- 1111 Kane Concourse
- Suite 301
- Bay Harbor Islands, FL 33154
- United States
Fortress Biotech Timeline
Fortress Biotech Stock Performance
As of 12-Nov-2026, Fortress Biotech’s stock price is $1.98. Its current market cap is $66.4M with 33.4M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.98 | $2.01 | $1.79 - $4.53 | $66.4M | 33.4M | 298K | $3.24 |
Fortress Biotech Financials Summary
As of 30-Jun-2026, Fortress Biotech has a trailing 12-month revenue of $68.5M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | (60,395) | 105,000 | 34,683 | 12,559 |
| Revenue | 68,466 | 63,262 | 57,675 | 84,513 |
| EBITDA | 154,072 | (22,650) | (107,174) | (138,724) |
| Net Income | 111,818 | 6,815 | (45,997) | (60,637) |
| Total Assets | 316,715 | 185,548 | 144,223 | 167,526 |
| Total Debt | 53,316 | 74,301 | 75,960 | 84,661 |
Fortress Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Fortress Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Fortress Biotech Comparisons
Industry
Financing
Details
Fortress Biotech Competitors (37)
One of Fortress Biotech’s 37 competitors is Rhythm Pharmaceuticals, a Formerly VC-backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals | Formerly VC-backed | Boston, MA | ||||
| Arecor Therapeutics | Formerly VC-backed | Little Chesterford, United Kingdom | ||||
| CNS Pharmaceuticals | Formerly Angel backed | Houston, TX | ||||
| Affimed | Formerly VC-backed | Mannheim, Germany | ||||
| BioAtla | Formerly VC-backed | San Diego, CA |
Fortress Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Fortress Biotech Patents
Fortress Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11376263-B2 | Cyproterone acetate compositions and uses thereof | Inactive | 08-Oct-2020 | ||
| US-20220110947-A1 | Cyproterone acetate compositions and uses thereof | Active | 08-Oct-2020 | ||
| US-20220313705-A1 | Cyproterone acetate compositions and uses thereof | Inactive | 08-Oct-2020 | ||
| WO-2022076733-A1 | Cyproterone acetate compositions and uses thereof | Inactive | 08-Oct-2020 | ||
| US-10590199-B2 | Pd-l1-specific antibodies and methods of using the same | Active | 29-Jun-2016 | C07K16/2827 |
Fortress Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Fortress Biotech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Fortress Biotech Investments & Acquisitions (5)
Fortress Biotech’s most recent deal was a Early Stage VC with Helocyte for . The deal was made on 03-Nov-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Helocyte | 03-Nov-2016 | Early Stage VC | Biotechnology | ||
| National Holdings | 30-Sep-2016 | Merger/Acquisition | Asset Management | ||
| Origo Acquisition | 07-Jan-2015 | PIPE | Special Purpose Acquisition Company (SPAC) | ||
| Nuro Pharma | 12-May-2014 | Early Stage VC | Other Healthcare Services | ||
| Ovamed (TSO Manufacturing Rights) | 27-Dec-2012 | Corporate Asset Purchase | Buildings and Property |
Fortress Biotech ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
40.09 | Severe Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Biotechnology
Subindustry
of 431
Rank
Percentile
Fortress Biotech Exits (3)
Fortress Biotech’s most recent exit was on 30-Sep-2016 from National Holdings. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| National Holdings | 30-Sep-2016 | Completed |
|
||
| Origo Acquisition | 07-Jan-2015 | Completed |
|
||
| Nuro Pharma | 12-May-2014 | Early Stage VC | Completed |
|
Fortress Biotech Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Escala Therapeutics | New York, NY |
Fortress Biotech FAQs
-
When was Fortress Biotech founded?
Fortress Biotech was founded in 2006.
-
Where is Fortress Biotech headquartered?
Fortress Biotech is headquartered in Bay Harbor Islands, FL.
-
What is the size of Fortress Biotech?
Fortress Biotech has 78 total employees.
-
What industry is Fortress Biotech in?
Fortress Biotech’s primary industry is Drug Discovery.
-
Is Fortress Biotech a private or public company?
Fortress Biotech is a Public company.
-
What is Fortress Biotech’s stock symbol?
The ticker symbol for Fortress Biotech is FBIO.
-
What is the current stock price of Fortress Biotech?
As of 12-Nov-2026 the stock price of Fortress Biotech is $1.98.
-
What is the current market cap of Fortress Biotech?
The current market capitalization of Fortress Biotech is $66.4M.
-
What is Fortress Biotech’s current revenue?
The trailing twelve month revenue for Fortress Biotech is $68.5M.
-
Who are Fortress Biotech’s competitors?
Rhythm Pharmaceuticals, Arecor Therapeutics, CNS Pharmaceuticals, Affimed, and BioAtla are some of the 37 competitors of Fortress Biotech.
-
What is Fortress Biotech’s annual earnings per share (EPS)?
Fortress Biotech’s EPS for 12 months was $3.24.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
